Indian Health Service (Department of Health and Human Services)

Indianz.Com > COVID-19 > Indian Health Service (Department of Health and Human Services)

Posted: April 18, 2021

Photo courtesy Indian Health Service

A message to patients who have received the Johnson & Johnson/Janssen COVID-19 vaccine

The following message was posted by the Indian Health Service in connection with the temporary pause on the administration of the Johnson & Johnson/Janssen COVID-19 vaccine.

Out of an abundance of caution, the Indian Health Service has paused the use of the Johnson & Johnson/Janssen COVID-19 vaccine as the Food and Drug Administration and the Centers for Disease Control and Prevention reviews data involving six reported U.S. cases of an extremely rare and severe type of blood clot in individuals after receiving the Johnson & Johnson/Janssen vaccine.

Seek medical care urgently if you develop any of the following symptoms:

severe headache,
backache,
new neurologic symptoms,
severe abdominal pain,
shortness of breath,
leg swelling,
tiny red spots on the skin (petechiae), or
new or easy bruising

To date, there have been no cases reported through IHS of the rare and severe type of blood clot seen in some individuals who have received the Johnson & Johnson/Janssen vaccine.

If you had an appointment scheduled to receive the Johnson & Johnson/Janssen COVID-19 vaccine talk to your health care provider about whether the Pfizer or Moderna vaccine is available and appropriate for you.

Join the Conversation